Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Instituto Nacional de Cancerologia E.S.E (Site 1095)

Bogota, Cundinamarca 111511, ColombiaNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Cervical cancer

Closed trials

Completed
Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)
NCT03635567· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Instituto Nacional de Cancerologia E.S.E (Site 1095): trial site – Frontlight Research